Etropal AD (XBUL:ETR) EPS (Basic) : лв0.40 (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Etropal AD EPS (Basic)?

Etropal AD's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was лв0.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.40.

Etropal AD's EPS (Diluted) for the six months ended in Dec. 2024 was лв0.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.40.

Etropal AD's EPS without NRI for the six months ended in Dec. 2024 was лв0.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.44.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Etropal AD's highest 3-Year average EPS without NRI Growth Rate was 100.00% per year. The lowest was 46.50% per year. And the median was 69.40% per year.

Etropal AD EPS (Basic) Historical Data

The historical data trend for Etropal AD's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD EPS (Basic) Chart

Etropal AD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.01

-0.70

-0.10

-0.30

0.40

Etropal AD Semi-Annual Data
	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec20	Dec21	Dec22	Dec23	Dec24
EPS (Basic)	Get a 7-Day Free Trial									0.01	-0.70	-0.10	-0.30	0.40

Etropal AD EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Etropal AD's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.089	-	0)	/	5.000
	=	0.02

Etropal AD's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.089	-	0)	/	5.000
	=	0.02

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.40

Etropal AD (XBUL:ETR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Etropal AD EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Etropal AD's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Etropal AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Rusky Boulevard, Etropole, Sofia, BGR, 2180

Website

http://www.etropal.eu

Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.